Total weight loss by week 12 typically ranges from 5% to 8% of starting body weight, depending on the medication and dose
5 press release
A novel dual glucagon-like peptide and glucagon receptor agonist SAR425899: results of randomized, placebo-controlled first-in-human and first-in-patient trials
Despite this, people with type 2 diabetes tend to lose less weight on a GLP-1 than people who don't have the condition, and for reasons that aren't quite clear, says Silvana Obici, MD, chief of the division of endocrinology at Stony Brook Medicine and medical director of the Stony Brook University Hospital Diabetes Center in New York
So lymphedema therapy, surgical reconstruction when appropriate, and possibly GLP-1, or the next best drug as it comes to light, is really, they're complementary and sort of the ideal approach
Lets take a closer look at how retatrutide dosing has been tested in clinical trials and what those findings might mean for future use